Title:"Bioinformatics analyses ti elucidate the class IIa HDACs-MEF2 oncogenic potential in colorectal cancer and leiomyosarcoma"

Supervisor: Prof. C. Brancolini/ dr. E. Dalla

Publications:

• Pubblicazione: Minisini, M., Di Giorgio, E., Kerschbamer, E., Dalla, E., Faggiani, M., Franforte, E., Meyer-Almes, F.-J., Ragno, R., Antonini, L., Mai, A., Fiorentino, F., Rotili, D., Chinellato, M., Perin, S., Cendron, L., Weichenberger, C. X., Angelini, A., & Brancolini, C. (2022). Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription. Nucleic Acids Research, 50(5), 2566–2586.